Bicara Therapeutics (BCAX) Capital Expenditures (2023 - 2026)
Bicara Therapeutics posted quarterly Capital Expenditures of $60000.0 for Q1 2026, down 74.79% on a QoQ basis from $238000.0 in Q4 2025.
Bicara Therapeutics (BCAX) has 4 years of Capital Expenditures data on file, last reported at $60000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures changed N/A year-over-year to $60000.0; the trailing twelve-month figure through Mar 2026 stood at $340000.0 (up 407.46% YoY), and the FY2025 full-year result was $280000.0, up 294.37% from the prior year.
- Capital Expenditures for Q1 2026 stood at $60000.0, down from $238000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $436000.0 in Q4 2023 and bottomed at $4000.0 in Q1 2024.
- The 4-year median for Capital Expenditures is $41000.0 (2024), against an average of $105875.0.
- The widest annual swing landed in 2024, when Capital Expenditures plunged 90.83%; it then jumped 495.0% in 2025.
- A 4-year view of Capital Expenditures shows it stood at $436000.0 in 2023, then slumped by 90.83% to $40000.0 in 2024, then surged by 495.0% to $238000.0 in 2025, then sank by 74.79% to $60000.0 in 2026.
- The last three Capital Expenditures figures came in at $60000.0 (Q1 2026), $238000.0 (Q4 2025), and $42000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Bicara Therapeutics | 1.25 Bn | 1.25 Bn | - | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 436,000.00 |
| Dec 31, 2023 | 436,000.00 |